Uncategorized
Glaukos Announces Participation in Upcoming Investor Conferences
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the following investor conferences: Goldman Sachs 37th Annual Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 8, 2016 at 1:20 p.m. PDT William Blair 2016 Growth
